Franklin Resources Inc Neurocrine Biosciences Inc Transaction History

Franklin Resources Inc

$334 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Franklin Resources Inc holds 664,336 shares of NBIX stock, worth $100 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

664,336

Previous 664,336 -0.0%

Holding current value

$100 Million

Previous $76.5 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$114.58 - $153.15 $16.5 Million - $22.1 Million	-144,114 Reduced 17.83%	664,336 $76.5 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $1.91 Million - $2.09 Million	14,625 Added 1.84%	808,450 $111 Million
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $2.81 Million - $3.09 Million	21,515 Added 2.79%	793,825 $109 Million
Q4 2023 Feb 09, 2024	BUY	$106.07 - $132.76 $649,572 - $813,022	6,124 Added 0.8%	772,310 $102 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $3.57 Million - $4.44 Million	37,936 Added 5.21%	766,186 $86.2 Million
Q2 2023 Aug 11, 2023	BUY	$89.53 - $104.87 $1.59 Million - $1.87 Million	17,806 Added 2.51%	728,250 $68.7 Million
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $1.57 Million - $2.05 Million	16,672 Added 2.4%	710,444 $71.9 Million
Q4 2022 Feb 10, 2023	SELL	$106.72 - $127.06 $38.3 Million - $45.5 Million	-358,463 Reduced 34.07%	693,772 $82.9 Million
Q3 2022 Nov 14, 2022	SELL	$92.03 - $107.81 $11.9 Million - $13.9 Million	-128,820 Reduced 10.91%	1,052,235 $112 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $4.95 Million - $6.54 Million	65,313 Added 5.85%	1,181,055 $115 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $11 Million - $14.4 Million	151,921 Added 15.76%	1,115,742 $105 Million
Q4 2021 Feb 11, 2022	SELL	$79.65 - $106.22 $16,168 - $21,562	-203 Reduced 0.02%	963,821 $82.1 Million
Q3 2021 Nov 12, 2021	BUY	$86.18 - $99.03 $128,408 - $147,554	1,490 Added 0.15%	964,024 $92.5 Million
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $5.16 Million - $5.9 Million	57,680 Added 6.37%	962,534 $93.7 Million
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $874,298 - $1.19 Million	9,984 Added 1.12%	904,854 $88 Million
Q4 2020 Feb 10, 2021	SELL	$86.91 - $108.33 $55.2 Million - $68.8 Million	-635,290 Reduced 41.52%	894,870 $85.8 Million
Q3 2020 Nov 12, 2020	BUY	$96.16 - $135.15 $7.49 Million - $10.5 Million	77,878 Added 5.36%	1,530,160 $147 Million
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $19.2 Million - $29.4 Million	-225,399 Reduced 13.44%	1,452,282 $189 Million
Q1 2020 May 13, 2020	SELL	$75.11 - $113.76 $23 Million - $34.8 Million	-305,818 Reduced 15.42%	1,677,681 $145 Million
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $10.7 Million - $14.6 Million	122,980 Added 6.61%	1,983,499 $213 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $17.5 Million - $21.2 Million	208,688 Added 12.63%	1,860,519 $168 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $28 Million - $35.3 Million	-387,307 Reduced 18.99%	1,651,831 $139 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $984,202 - $1.3 Million	14,200 Added 0.7%	2,039,138 $180 Million
Q4 2018 Feb 12, 2019	BUY	$68.32 - $124.36 $12.6 Million - $22.9 Million	184,415 Added 10.02%	2,024,938 $145 Million
Q3 2018 Nov 13, 2018	BUY	$98.88 - $125.85 $1.5 Million - $1.9 Million	15,137 Added 0.83%	1,840,523 $226 Million
Q2 2018 Aug 14, 2018	SELL	$75.3 - $105.99 $40 Million - $56.3 Million	-531,200 Reduced 22.54%	1,825,386 $179 Million
Q1 2018 May 10, 2018	SELL	$75.88 - $92.43 $54.2 Million - $66.1 Million	-714,800 Reduced 23.27%	2,356,586 $195 Million
Q4 2017 Feb 14, 2018	SELL	$58.53 - $77.59 $11.4 Million - $15.1 Million	-194,229 Reduced 5.95%	3,071,386 $238 Million
Q3 2017 Nov 13, 2017	BUY	$47.97 - $61.28 $157 Million - $200 Million	3,265,615	3,265,615 $200 Million

Others Institutions Holding NBIX

# of Institutions

642

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Neurocrine Biosciences Inc Transaction History